findmyKOL
Clinical trialNCT06458907Not, yet, recruitingInterventional

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

SponsorP+F Products + Features USA Inc.Enrollment780Cardiovascular DiseasesHeart FailureHeart Valve DiseasesTricuspid Valve DiseaseTricuspid Valve InsufficiencyTricuspid Valve Regurgitation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Pivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • St. Joseph'S Hospital and Medical Center

    Phoenix, Arizona, United States

  • Uc Davis Health

    Sacramento, California, United States

  • Scripps Memorial Hospital la Jolla

    San Diego, California, United States

  • Ucsf

    San Francisco, California, United States

  • Kaiser Permanente

    San Jose, California, United States

  • Medstar Washington Hospital Center (mwhc)

    Washington D.C., District of Columbia, United States

    Toby Rogers, MD
  • Delray Medical Center

    Delray Beach, Florida, United States

  • Hca Florida Largo Hospital

    Largo, Florida, United States

    Saurabh Sanon, MD
  • Tampa General Hospital

    Tampa, Florida, United States

  • Endeavor Health

    Glenview, Illinois, United States

  • Ascension Medical Group St. Vincent the Heart Center of Indiana

    Indianapolis, Indiana, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Cardiovascular Institute of the South

    Houma, Louisiana, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts, United States

  • Minneapolis Heart Institute Foundation

    Minneapolis, Minnesota, United States

  • Saint Luke'S Mid America Heart Institute

    Kansas City, Missouri, United States

  • Washington University of St Louis

    St Louis, Missouri, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Northwell Hospital

    Manhasset, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

    Rishi Puri, MD
  • Riverside Methodist Hospital

    Columbus, Ohio, United States

  • Oregon Health

    Portland, Oregon, United States

  • Musc

    Charleston, South Carolina, United States

  • Houston Methodist

    Houston, Texas, United States

  • University of Texas (memorial Hermann)

    Houston, Texas, United States

  • Baylor Scott & White Medical

    Plano, Texas, United States

  • Intermountain Heart Institute - Intermountain Medical Center

    Murray, Utah, United States

  • Uva School of Medicine

    Charlottesville, Virginia, United States

  • Sentara Healthcare

    Norfolk, Virginia, United States

  • Carilion Clinic

    Roanoke, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Optimal medical therapy
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2026
Primary completion
30 Nov 2028
Completion
30 Nov 2032
Last update posted
3 Aug 2026
Registered enrollment
780
Registry id
NCT06458907

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.